How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses

The global Covid-19 pandemic has forced us to put our lives on hold, and a vaccine is the most likely route back to normality. Vaccine development is in the limelight, and our need for one has led us to search for ways to speed up the process.

The UK was the first European country to approve a Covid-19 vaccine in December 2020. However, it took almost a year to reach this point, as vaccine development is a long and complex process. Typically, each pathogen needs its own vaccine manufacturing process. Stringent regulations and the lack of incentives make the process even more challenging.

Various approaches could drive the industry forward. New and improved technologies have the potential to speed up and simplify vaccine development. The creativity and expertise of biotechs have led to their prominent role in the development of many vaccines, including those for Covid-19.

Implementing new technologies

coronavirus, mRNA vaccine, Covid-19 pandemic

Improved platforms and rapid testing that streamlines safety and quality assessments could transform vaccine development.

The post How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses appeared first on Labiotech.eu.

Published on Tue, 12 Jan 2021 09:00:27 +0000 in support of salesforce collection starts with item